Azenta Q1 FY25 revenue rises 4% YoY to $148M; adjusted EBITDA margin improves 400 bps to 9.0%

Azenta, Inc.

2025-Q1 EPS reported -$0.29 revenue$147,510,000

GAAP diluted EPS from continuing ops -$0.21 (vs -$0.13 YoY); total diluted EPS -$0.29 (vs -$0.28).
Non-GAAP diluted EPS unchanged at $0.08; adjusted EBITDA $13M vs $7M in prior year.
Sample Management Solutions revenue $81M (+3% YoY); Multiomics $66M (+6% YoY).
Reaffirmed FY2025 guidance: organic revenue growth 3-5%, adjusted EBITDA margin expansion ~300 bps.
Free cash flow $22M; cash and marketable securities $530M including $27M from discontinued ops.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.